Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
1,321,183
-
Shares change
-
-32,478
-
Total reported value, excl. options
-
$12,486,000
-
Value change
-
-$435,598
-
Number of buys
-
17
-
Number of sells
-
-17
-
Price
-
$9.45
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2016
41 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2016.
XBiotech Inc. - Common Shares, no par value (XBIT) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,321,183 shares
of 33,289,095 outstanding shares and own 3.97% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (518,229 shares), VANGUARD GROUP INC (397,107 shares), NORTHERN TRUST CORP (44,685 shares), GEODE CAPITAL MANAGEMENT, LLC (41,170 shares), STATE STREET CORP (40,560 shares), ALPS ADVISORS INC (36,194 shares), BlackRock Institutional Trust Company, N.A. (34,001 shares), M Holdings Securities, Inc. (25,833 shares), ProShare Advisors LLC (24,312 shares), and SYNOVUS FINANCIAL CORP (17,672 shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.